8-KThe WireStrategic
Exit / Disposal Costs
Filed Nov 8, 2022 · 3y ago · Accession 0001193125-22-280142
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Nov 8, 2022
- Report date
- Nov 7, 2022
- Document
- d76469d8k.htm
- Size
- 144 KB